These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22133823)

  • 1. [Bone and calcium update; diagnosis and therapy of bone metabolism disease update. Calcification of atherosclerotic plaques: mechanism and clinical significance].
    Kurabayashi M
    Clin Calcium; 2011 Dec; 21(12):43-50. PubMed ID: 22133823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification.
    Quercioli A; Luciano Viviani G; Dallegri F; Mach F; Montecucco F
    Crit Pathw Cardiol; 2010 Dec; 9(4):227-30. PubMed ID: 21119343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in aged mice].
    Akiyoshi T; Ogawa S; Akishita M
    Clin Calcium; 2015 May; 25(5):671-7. PubMed ID: 25926570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification in chronic kidney disease: mechanisms and clinical implications.
    Ossareh S
    Iran J Kidney Dis; 2011 Sep; 5(5):285-99. PubMed ID: 21876304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is inflammation the link between atherosclerosis and vascular calcification in chronic kidney disease?
    Tsirpanlis G
    Blood Purif; 2007; 25(2):179-82. PubMed ID: 17261926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
    D'Amelio P; Isaia G; Isaia GC
    J Endocrinol Invest; 2009; 32(4 Suppl):6-9. PubMed ID: 19724159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular calcification: mutual interaction between bone and blood vessel].
    Yamaguchi A; Akashi T
    Clin Calcium; 2010 Nov; 20(11):1669-76. PubMed ID: 21037387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification as a clinical manifestation of bone-vascular axis].
    Yamamoto M
    Clin Calcium; 2015 May; 25(5):655-60. PubMed ID: 25926568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification.
    Osako MK; Nakagami H; Koibuchi N; Shimizu H; Nakagami F; Koriyama H; Shimamura M; Miyake T; Rakugi H; Morishita R
    Circ Res; 2010 Aug; 107(4):466-75. PubMed ID: 20595654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity.
    Venuraju SM; Yerramasu A; Corder R; Lahiri A
    J Am Coll Cardiol; 2010 May; 55(19):2049-61. PubMed ID: 20447527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Role of vascular smooth muscle cells in vascular calcification].
    Kurabayashi M
    Clin Calcium; 2015 May; 25(5):661-9. PubMed ID: 25926569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of RANK, RANKL, and osteoprotegerin.
    Boyce BF; Xing L
    Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S1. PubMed ID: 17634140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone and calcium update; diagnosis and therapy of bone metabolism disease update. Molecular mechanism in cardiac valve calcification].
    Furukawa K; Motomura S
    Clin Calcium; 2011 Dec; 21(12):61-6. PubMed ID: 22133825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary calcification identifies the vulnerable patient rather than the vulnerable Plaque.
    Mauriello A; Servadei F; Zoccai GB; Giacobbi E; Anemona L; Bonanno E; Casella S
    Atherosclerosis; 2013 Jul; 229(1):124-9. PubMed ID: 23578355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variants of MGP are associated with calcification on the arterial wall but not with calcification present in the atherosclerotic plaques.
    Wang Y; Chen J; Zhang Y; Yu W; Zhang C; Gong L; Shao L; Lu J; Gao Y; Chen X; Chen X; Hui R
    Circ Cardiovasc Genet; 2013 Jun; 6(3):271-8. PubMed ID: 23677904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes.
    Davaine JM; Quillard T; Chatelais M; Guilbaud F; Brion R; Guyomarch B; Brennan MÁ; Heymann D; Heymann MF; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):259-67. PubMed ID: 26652270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
    Collin-Osdoby P
    Circ Res; 2004 Nov; 95(11):1046-57. PubMed ID: 15564564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
    Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
    Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of calcification in blood and urine.
    Schlieper G; Westenfeld R; Brandenburg V; Ketteler M
    Semin Dial; 2007; 20(2):113-21. PubMed ID: 17374084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.